Publication

Real-World eligibility for dapagliflozin in unselected heart failure patients: Data from the CORDIS-HF registry

Could dapagliflozin help people suffering from heart failure? This study aimed to investigate which proportion of patients with Heart Failure would be eligible for DAPA treatment in a real-world clinical practice.

Download Publication
Talk to an Expert

Download the research abstract

This study aimed to investigate which proportion of patients with Heart Failure would be eligible for DAPA treatment in a real-world clinical practice.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.